Skip to content
Education Training, Medical Health Aged Care

New Program from Doctors For Nutrition Aims to Transform Diabetes Care for Doctors and Patients

Doctors For Nutrition 2 mins read

The problem:

Diabetes is a rapidly growing global health challenge, affecting 589 million adults—around 1 in 9 people—with numbers projected to rise by 45% to 853 million by 2050. In Australia alone, more than 1.3 million people are living with diabetes, with a new diagnosis every five minutes, making it the country’s fastest-growing chronic condition. The burden is disproportionately higher among Aboriginal and Torres Strait Islander peoples, who face significantly greater risks of developing, being hospitalised for, and dying from type 2 diabetes.

Many health professionals report limited training and low confidence in providing structured nutrition and lifestyle counselling for type 2 diabetes risk reduction. Our new course has been designed to help close that gap.

The solution:

Doctors For Nutrition, an independent not-for-profit committed to evidence-based education, announces ‘Overcoming Diabetes in Clinical Practice’— an on‑demand, RACGP and ACRRM–approved activity designed for GPs and primary care clinicians who want practical, evidence-based strategies to help patients prevent, manage, and in many cases reverse type 2 diabetes using nutrition and other lifestyle interventions, alongside appropriate pharmacotherapy.

Overcoming Diabetes at a glance:

Developed by Australian doctors and health experts, Overcoming Diabetes in Clinical Practice is a fully-referenced, fact-based and accessible on-demand program that covers:

  • Clear explanations of how diet and lifestyle impact health and diabetes risk

  • Practical guidance, recipes, and resources to support change

  • Evidence-based information for doctors treating patients living with type 2 diabetes, at risk, or wanting to protect their health long-term

“Type 2 diabetes affects thousands of Australian families every year, but there is hope—prevention and reversal are possible,” said Rebecca Stonor, DFN CEO. “This course empowers doctors and medical professionals to help their patients take charge of their health, by focussing on the underlying causes of type 2 diabetes— all backed by the latest nutrition science.”

There is also a ‘patient-focused’ program that is an excellent resource for the medical community to recommend to their patients and is a trusted companion for clinical care. Overcoming Diabetes, has been developed as an on-demand course for anyone living with—or looking to prevent—type 2 diabetes.  

Access the two courses:

 


About us:

Doctors For Nutrition is an independent, registered charity founded in 2018 with the mission to inspire the healthcare sector, policymakers, and society at large to integrate whole food plant-based nutrition and other lifestyle medicine principles as powerful tools for disease prevention and care. With a team of medical and dietetic practitioners across Australia, New Zealand, and globally, Doctors For Nutrition works to equip clinicians, institutions, and communities with evidence-based education and resources on optimal human nutrition-led lifestyle medicine strategies to prevent, alleviate, and even reverse chronic diseases, aiming to create a world free from preventable disease where everyone can thrive and live to their full potential.


Contact details:

Rebecca Stonor, CEO
Doctors For Nutrition
[email protected]
0413309944

Media

More from this category

  • Education Training
  • 16/04/2026
  • 15:41
Education Centre of Australia

ECA Expands Global Campus Network Through Birkbeck, University of London Partnership in India

Key Facts: ECA partners with Birkbeck, University of London to establish a new international campus in Bengaluru's Sattva Tech Park, offering degrees at up…

  • Contains:
  • Finance Investment, Medical Health Aged Care
  • 16/04/2026
  • 15:21
JMM

BlinkLab Secures A$17.5M to Advance FDA Trial and Commercial Launch of AI-Powered Autism Diagnostic, Expands ADHD Program

BlinkLab Limited (ASX: BB1) a digital healthcare company developing AI-powered diagnostic technologies, has secured A$17.5 million in an oversubscribed placement to institutional and sophisticated investors, positioning the Company to accelerate regulatory milestones and commercialisation of its lead autism diagnostic platform while expanding into the significantly larger ADHD market. The capital raise, priced at A$0.65 per share, marks a critical inflection point for BlinkLab as it advances toward FDA approval and market entry for BlinkLab Dx1, its smartphone-based diagnostic aid for autism. Funding to Accelerate Regulatory Pathway and Commercial Readiness Proceeds from the placement will be deployed across key value-driving initiatives,…

  • Contains:
  • Medical Health Aged Care
  • 16/04/2026
  • 15:11
Galderma

Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+(TM), Powered by Its Next-Generation TriHex Technology® Regenerative Platform

Regenerating Skin Nectar has long played a central role in the peri-procedural skin journey as part of Alastin’s dedicated procedure support portfolio, enhancing the…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.